Home Industry Reports Custom Research Blogs About Us Contact us

Pet癌症治疗市场规模和份额, 由治疗(化学疗法,免疫疗法,定向疗法,结合疗法,辐射疗法,外科手术),应用(母细胞癌,淋巴瘤,梅拉诺玛,乳腺和平胃细胞癌),区域预测,工业玩家,增长统计报告2024-2032年.

Report ID: FBI 5944

|

Published Date: Aug-2024

|

Format : PDF, Excel

市场展望:

2023年,Pet Cancer治疗市场超过41,122万美元,预计到2032年底将超过97,760万美元,2024至2032年的CAGR约为10.1%。

Base Year Value (2023)

USD 411.22 Million

19-23 x.x %
24-32 x.x %

CAGR (2024-2032)

10.1%

19-23 x.x %
24-32 x.x %

Forecast Year Value (2032)

USD 977.6 Million

19-23 x.x %
24-32 x.x %
Pet Cancer Therapeutics Market

Historical Data Period

2019-2023

Pet Cancer Therapeutics Market

Largest Region

North America

Pet Cancer Therapeutics Market

Forecast Period

2024-2032

Get more details on this report -

市场动态:

增长动力和机会:

宠物中癌症的日益流行和对宠物健康问题的认识的提高正在推动宠物癌症治疗市场的增长. 此外,兽医和技术的进步正在导致开发出更有效的宠物癌症治疗方法。

Report Scope

Report CoverageDetails
Segments CoveredTherapy, Applications
Regions Covered• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company ProfiledAB Science, Anivive Lifesciences, Elanco Animal Health, ELIAS Animal Health, Merial, NovaVive, Qbiotics, Zoetis

Unlock insights tailored to your business with our bespoke market research solutions - Click to get your customized report now!

Industry Restraints:

治疗费用高和宠物癌治疗有限是市场的主要制约因素。 对于许多宠物所有者来说,对宠物进行癌症治疗的成本高可能是一个障碍,限制了这些疗法的采用. 此外,某些地区的宠物癌专门治疗有限,也可能阻碍市场增长。

区域预报:

Pet Cancer Therapeutics Market

Largest Region

North America

71% Market Share in 2023

Get more details on this report -

北美:

北美地区,包括美国和加拿大,由于宠物所有权不断提高,对宠物健康的认识不断提高,以及动物保健支出不断增加,预计会主导宠物癌治疗市场. 主要制药公司和研究机构集中力量治疗宠物癌症,也促进了市场的增长。

亚太:

在亚太地区,中国、日本和韩国等国的宠物癌症治疗市场正在大幅增长。 不断增加的可支配收入,改变生活方式,以及越来越多的宠物被收养,正在推动这一地区对宠物进行先进的癌症治疗的需求. 此外,大量宠物拥有者的存在以及宠物中癌症发病率的上升正在推动市场增长。

欧洲:

在欧洲,英国、德国和法国等国的宠物癌症治疗市场正在稳步增长。 对宠物健康的日益关注、宠物人口的不断增长以及兽医的进步,正在推动本区域的市场增长。 此外,既有兽药公司和研究设施的存在,有助于为宠物开发创新的癌症治疗方法。

Report Coverage & Deliverables

Historical Statistics Growth Forecasts Latest Trends & Innovations Market Segmentation Regional Opportunities Competitive Landscape
Pet Cancer Therapeutics Market
Pet Cancer Therapeutics Market

细分分析:

""

在分化方面,根据"治疗","应用",分析了全球的"宠物癌治疗"市场

治疗分析

化学疗法:

化疗是宠物癌治疗中常用的一种疗法,涉及用药物来杀死癌细胞. 它常常与其他疗法结合使用,以取得更有效的结果。

免疫治疗:

免疫疗法(英語:Immunography)是一类使用身体免疫系统来抗癌的疗法. 由于其定向方法和最小的副作用,它在宠物癌治疗中越来越受欢迎。

定向治疗:

定向疗法侧重于参与癌症生长的特定分子. 在传统治疗无效的情况下经常使用.

综合疗法:

结合疗法涉及使用多种治疗方式,从不同角度瞄准癌症. 常被推荐为有攻击性的癌症或疾病后期.

放射治疗:

辐射疗法使用高能束来杀死癌细胞. 它常被用在局部性癌症中或作为缓解治疗来降低症状.

外科手术:

外科手术是宠物癌的一种常见治疗方法,特别是可去除的固态肿瘤. 它往往与其他疗法相结合,以便采取综合治疗办法。

应用分析

马斯特细胞癌:

马斯特细胞癌是宠物中皮肤癌的一种常见形式,可以通过包括外科和化疗在内的综合疗法来治疗.

淋巴瘤:

淋巴瘤是一类会影响淋巴系统的癌症,可以通过化疗,免疫疗法,辐射疗法来治疗.

梅拉诺马:

梅拉诺玛是一类会影响皮肤并可以通过外科手术,辐射疗法,免疫疗法来治疗的癌症.

乳癌:

乳癌是雌性宠物中常见的癌症,可以通过外科手术,化疗,定点治疗来治疗.

平分细胞癌:

Squamous细胞癌是一类皮肤癌,可以通过外科手术,辐射疗法,免疫疗法来治疗.

Get more details on this report -

竞争格局:

宠物癌症治疗市场的竞争环境特点是既有制药公司和新兴生物技术公司相结合,注重创新疗法,以防治宠物癌症。 随着宠物健康意识的不断提高和兽医学的进步,公司正投资研发,将新颖的治疗带入市场. 市场认为,在关键角色努力区分产品供应时,有多种办法,包括化疗、免疫疗法和有针对性的疗法。 战略伙伴关系、合并和收购以及与兽医诊所和大学的合作是提高市场地位并加快开发新疗法的共同战略。

顶级市场玩家

- 苏提斯

- 埃兰科动物保健

- 默克动物保健

- 拜耳动物保健

- 维巴克

- PetCure肿瘤学

- 阿拉塔纳疗法

- Karyopharm疗法

- 兽医发展中心

- 轴心

Our Clients

Why Choose Us

Specialized Expertise: Our team comprises industry experts with a deep understanding of your market segment. We bring specialized knowledge and experience that ensures our research and consulting services are tailored to your unique needs.

Customized Solutions: We understand that every client is different. That's why we offer customized research and consulting solutions designed specifically to address your challenges and capitalize on opportunities within your industry.

Proven Results: With a track record of successful projects and satisfied clients, we have demonstrated our ability to deliver tangible results. Our case studies and testimonials speak to our effectiveness in helping clients achieve their goals.

Cutting-Edge Methodologies: We leverage the latest methodologies and technologies to gather insights and drive informed decision-making. Our innovative approach ensures that you stay ahead of the curve and gain a competitive edge in your market.

Client-Centric Approach: Your satisfaction is our top priority. We prioritize open communication, responsiveness, and transparency to ensure that we not only meet but exceed your expectations at every stage of the engagement.

Continuous Innovation: We are committed to continuous improvement and staying at the forefront of our industry. Through ongoing learning, professional development, and investment in new technologies, we ensure that our services are always evolving to meet your evolving needs.

Value for Money: Our competitive pricing and flexible engagement models ensure that you get maximum value for your investment. We are committed to delivering high-quality results that help you achieve a strong return on your investment.

Select Licence Type

Single User

US$ 4250

Multi User

US$ 5050

Corporate User

US$ 6150

Pet癌症治疗市场规模和份额, 由治疗(...

RD Code : 24